Inventor
MCGUIGAN CHRISTOPHER
GB38 patents
⚠️ This page may combine multiple inventors who share the name “MCGUIGAN CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NuCana plc
12 patentsUSRE47589ESep 3, 2019
Phosphoramidate compounds and methods of use
NuCana plc34 citations94
US10022390B2Jul 17, 2018
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
NuCana plc13 citations91
US11559542B2Jan 24, 2023
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
NuCana plc3 citations83
US10993957B2May 4, 2021
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
NuCana plc4 citations83
US10570168B2Feb 25, 2020
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds
NuCana plc5 citations80
US10906929B2Feb 2, 2021
Phosphoramidate nucleoside derivatives as anticancer agents
NuCana plc2 citations71
US10662213B2May 26, 2020
Gemcitabine prodrugs
NuCana plc3 citations71
US11352387B2Jun 7, 2022
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
NuCana plc2 citations69
US11925658B2Mar 12, 2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer
NuCana plc0 citations61
US11629164B2Apr 18, 2023
Gemcitabine prodrugs
NuCana plc0 citations60
US11040997B2Jun 22, 2021
Process for preparing nucleoside prodrugs
NuCana plc0 citations59
US12054510B2Aug 6, 2024
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
NuCana plc0 citations57
MCGUIGAN CHRISTOPHER
8 patentsUS8933053B2Jan 13, 2015
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
MCGUIGAN CHRISTOPHER37 citations96
US8658616B2Feb 25, 2014
Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus
MCGUIGAN CHRISTOPHER55 citations90
US8263575B2Sep 11, 2012
Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
MCGUIGAN CHRISTOPHER29 citations87
US8551965B2Oct 8, 2013
Anti-viral pyrimidine nucleoside analogues
MCGUIGAN CHRISTOPHER5 citations84
US8119779B2Feb 21, 2012
Phosphoramidate derivatives
MCGUIGAN CHRISTOPHER35 citations84
US8329664B2Dec 11, 2012
Anti-viral pyrimidine nucleoside derivatives
MCGUIGAN CHRISTOPHER6 citations82
US9321798B2Apr 26, 2016
Phosphoramidite derivatives of gemcitabine for use in the treatment of cancer
MCGUIGAN CHRISTOPHER4 citations73
US8551966B2Oct 8, 2013
Chemical compounds
MCGUIGAN CHRISTOPHER0 citations36
UNIV CARDIFF
6 patentsUS7018989B2Mar 28, 2006
Chemical compounds
UNIV CARDIFF91 citations98
US6455513B1Sep 24, 2002
Chemical compounds
UNIV CARDIFF118 citations98
US7115590B1Oct 3, 2006
Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
UNIV CARDIFF32 citations92
US6638919B2Oct 28, 2003
Antiviral purine derivatives
UNIV CARDIFF35 citations92
US6573247B1Jun 3, 2003
Anti-viral pyrimidine nucleoside analogues
UNIV CARDIFF36 citations90
US8859512B2Oct 14, 2014
Anti-viral pyrimidine nucleoside derivatives
UNIV CARDIFF3 citations61